Issuer · CIK 0001787306
ARQT — Arcutis Biotherapeutics, Inc.
⚡ SELL CLUSTER · last 7 days
2 insiders sold $ARQT on Jun 18, 2026.
Cluster patterns historically carry stronger directional signal than any single insider trade. Upgrade to Pro to see the cluster total and per-insider dollar amounts. Read the methodology →
LIN SUE-JEAN
director
$•••
Jun 18, 2026
Welgus Howard G.
director
$•••
Jun 18, 2026
Recent filings
- Jun 18, 2026·Form 4·Pro · in 18m$•••K
ARQT/Arcutis Biotherapeutics, Inc.
LIN SUE-JEAN · director
Proonly - Jun 18, 2026·Form 4·Pro · in 11m$•••K
ARQT/Arcutis Biotherapeutics, Inc.
Welgus Howard G. · director
Proonly - Jun 12, 2026·Form 4/A·Other—
ARQT/Arcutis Biotherapeutics, Inc.
Heron Patrick J · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
ARQT/Arcutis Biotherapeutics, Inc.
Heron Patrick J · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
ARQT/Arcutis Biotherapeutics, Inc.
LIN SUE-JEAN · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
ARQT/Arcutis Biotherapeutics, Inc.
Welgus Howard G. · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
ARQT/Arcutis Biotherapeutics, Inc.
Leonard Keith R · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
ARQT/Arcutis Biotherapeutics, Inc.
Curran Terrie · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
ARQT/Arcutis Biotherapeutics, Inc.
Munshi Amit · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
ARQT/Arcutis Biotherapeutics, Inc.
Gilbert Halley E · director
Mechanical filing
AI thesis skipped - Jun 10, 2026·Form 4·Other—
ARQT/Arcutis Biotherapeutics, Inc.
Krishnamohan Neha · director
Mechanical filing
AI thesis skipped - May 13, 2026·Form 4·Sell$9.2K
ARQT/Arcutis Biotherapeutics, Inc.
Vairavan Latha · SVP Chief Financial Officer
12conviction - May 13, 2026·Form 4·Sell$4.7K
ARQT/Arcutis Biotherapeutics, Inc.
Burnett Patrick · See Remarks
8conviction - May 6, 2026·Form 4·Sell$171.5K
ARQT/Arcutis Biotherapeutics, Inc.
Matsuda Masaru · See Remarks
22conviction - May 6, 2026·Form 4·Sell$16.1K
ARQT/Arcutis Biotherapeutics, Inc.
Burnett Patrick · See Remarks
18conviction - May 6, 2026·Form 4·Sell$31.7K
ARQT/Arcutis Biotherapeutics, Inc.
Vairavan Latha · SVP Chief Financial Officer
22conviction - May 6, 2026·Form 4·Sell$74.9K
ARQT/Arcutis Biotherapeutics, Inc.
Watanabe Todd · See Remarks
22conviction - May 6, 2026·Form 4·Sell$164.2K
ARQT/Arcutis Biotherapeutics, Inc.
Welgus Howard G. · director
22conviction - Feb 4, 2026·Form 4·Sell$489.1K
ARQT/Arcutis Biotherapeutics, Inc.
Matsuda Masaru · See Remarks
32conviction